ISRCTN12926361进行中（未招募）1 期
Phase 1 trial, HMR code: 21-004 The full scientific title will be published within 30 months after the end of the trial
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 入组人数
- 104
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- Male
入选标准
- •Healthy human volunteer
排除标准
- •The Health Research Authority (HRA) has approved deferral of publication of the full details of the trial. The full details will be added to the study record when the results are published, which will be within 30 months after the trial has ended.
研究者
相似试验
已完成
1 期
Phase I trial, HMR code: 21-014The sponsor has confirmed that the trial meets the criteria for deferral of publication of the full details of the trial. The full details will be added to the study record within 30 months after the trial has ended.ISRCTN58651193Silence Therapeutics (United Kingdom)32
进行中（未招募）
1 期
Phase 1 trial HMR code: 23-001Healthy volunteersISRCTN15245786Medherant Limited24
进行中（未招募）
1 期
Phase 1 trial HMR code: 23-011Healthy volunteersISRCTN17328380Asceneuron (Switzerland)16
进行中（未招募）
1 期
Phase 1 trial HMR code: 22-017Healthy volunteersISRCTN51803225eurocrine Biosciences (United States)134
已完成
1 期
Phase 1 trial HMR code: 22-006Healthy volunteersISRCTN34662787Heptares Therapeutics (United Kingdom)16